Jeanny B. Aragon-Ching MD FACP, FASCO

Genitourinary Oncology

Wohlscheid Director, Genitourinary Oncology Research, Inova Schar Cancer; Clinical Program Director of Genitourinary Cancers; Medical Director of Clinical Research; Inova Schar Cancer Institute; Associate Professor of Medical Education, University of Virginia

Join to view full profile

8081 Innovation Park DrLevel 5 - Great Falls ClinicFairfax, VA 22031
Phone+1 571-472-1180
Fax+1 571-472-1197

Dr. Aragon-Ching is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aragon-Ching's full profile Already have an account?

Summary

Jeanny Aragon-Ching, MD, FACP, FASCO, is a renowned oncologist based in Fairfax, VA, specializing in genitourinary oncology. She currently serves as the Clinical Program Director of Genitourinary Oncology at Inova Schar Cancer Institute and the Medical Director of Clinical Research. Holds academic appointment as Associate Professor of Medical Education, University of Virginia. She completed her residency and chief residency in Internal Medicine at the Albert Einstein Healthcare Network, then pursued a fellowship in Hematology and Medical Oncology at the National Institutes of Health Clinical Center. Dr. Aragon-Ching currently serves as a GU Medical Oncologist at Inova Fairfax Hospital, adding on to her previous experience as an Assistant Professor at George Washington University Medical Center then promoted to Associate Professor at George Washington University Medical Center. She has contributed numerous publications and has been involved in a range of clinical trials, particularly in the areas of prostate and bladder cancer. Recognized for her expertise, she received numerous honors, including being named a Top Doctor by Northern Virginia Magazine, Washingtonian, and International Association of Oncologists, and voted America's Best Prostate Cancer Oncologists 2024, as well as participated in the ASCO Leadership Development Program and chaired and presented in various meetings.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2008
Albert Einstein Healthcare NetworkChief Residency, Internal Medicine, 2003 - 2004
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2000 - 2003
University of Santo TomasClass of 1997
University of Santo TomasBS, Physical Therapy, Cum Laude, 1988 - 1993

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 2015 - 2026
DC State Medical License 2008 - 2018
MD State Medical License 2004 - 2018
PA State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow of American Society of Clinical Oncology (FASCO) ASCO, 2025
America's Best Prostate Cancer Oncologists 2024 Newsweek, 2024
Named Top Doctor Northern Virginia Magazine, 2017, 2019-2021

Clinical Trials

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
COMPLETED
PHASE3
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
COMPLETED
PHASE1, PHASE2
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
COMPLETED
PHASE3

Publications & Presentations

PubMed

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III A...
Karim Fizazi, Matthew R Smith, Maha Hussain, Fred Saad, Cora N Sternberg
European Journal of Cancer. 2026-08-26
Current poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi) in metastatic prostate cancer: uses and controversies.
Farhan Azad, Eseoghene Kevu, Jeanny B Aragon-Ching
Expert Opinion on Pharmacotherapy. 2026-08-21
Transdermal estradiol (tE2) as an alternative androgen deprivation therapy (ADT) in locally advanced prostate cancer.
Ame Stephanie Ayemere, Jeanny B Aragon-Ching
Translational Cancer Research. 2026-07-31

Journal Articles

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Cora N Sternberg, Jeanny B Aragon-Ching, Daniel P Petrylak, Petros Grivas, The New England Journal of Medicine
The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer
Nizam A, Logan R, Gupta B, Aragon-Ching, JB, Kidney Cancer, 8/7/2019

Lectures

Metastatic RCC trials: Balancing efficacy and quality-of-life
EAU Annual Congress 2021 - 7/9/2021
Current Approaches to Urothelial and Variant Cancers: Tumor Board Presentation
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
ABCs of ADT
Hotel Monaco, Washington, DC; National Alliance of State Prostate Cancer Coalition - 10/19/2019

Other

The Benefits of Same-Day MDCs for Patients With Newly Diagnosed Cancers
Deeken J, Jones JS, Aragon-Ching JB, ASCO Daily News
https://dailynews.ascopubs.org/do/benefits-same-day-mdcs-patients-newly-diagnosed-cancers
Online - 3/25/2026
ASCO Podcast: Innovations in GU Cancer Treatment at ASCO25
Jeanny Aragon-Ching, MD and Neeraj Agrawal, MD, ASCO Daily News Pdocast
https://dailynews.ascopubs.org/do/podcast-innovations-gu-cancer-treatment-asco25
Online - 6/26/2025
Key Abstracts GU Cancers ASCO 2024
Neeraj Agrawal and JeannyAragon-Ching
https://dailynews.ascopubs.org/do/podcast-key-abstracts-gu-cancers-asco24
5/25/2024

Authored Content

Podcast: GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPARTJune 2026
Navigating the Toxicity Landscape of Antibody-Drug Conjugates in Urothelial CancersOctober 2025
How We Treat Metastatic Renal Cell Carcinoma: Options Beyond First-Line TherapyJanuary 2023

Press Mentions

KEYNOTE-B15: Enfortumab Vedotin Plus Pembrolizumab Improves OS, EFS, pCR Rates Over Chemotherapy in MIBCFebruary 27th, 2026
Three GU25 Studies Report on the Association Between Gut Microbiome Composition and Genitourinary CancersFebruary 13th, 2025
Radiotherapy-Based Approach Offers Lower Risk of Distant Metastases to Surgery in High-Risk Prostate CancerFebruary 14th, 2025

Committees

Associate Editor, ASCO Daily News 2021 - Present
Track Chair Urothelial Carcinoma, ASCO GU Cancers Symposium Committee 2019 2018 - Present
Member, Bladder; Track co-chair, Renal, ASCO GU Cancers Symposium Committee 2017 - 2018
Member, ASCO Cancer Education Committe 2016 - 2018
Member, Prostate; Track Chair - Renal, ASCO GU Cancers Committee 2016 - 2017